$QLGN
Qualigen Therapeutics, Inc.

2024 Q3 Form 10-Q Financial Statement

#000149315224032161 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $0.00 $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.145M $986.5K
YoY Change -14.33% -65.2%
% of Gross Profit
Research & Development $123.4K $754.3K
YoY Change -91.44% -43.14%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.269M $1.741M
YoY Change -54.34% -66.38%
Operating Profit -$1.269M -$1.741M
YoY Change -54.34% -50.98%
Interest Expense $28.00K $168.0K
YoY Change -107.62% -144.51%
% of Operating Profit
Other Income/Expense, Net -$527.7K $263.0K
YoY Change 15.55% 4903.82%
Pretax Income -$1.796M -$1.478M
YoY Change -44.47% -58.32%
Income Tax -$2.198K -$1.212K
% Of Pretax Income
Net Earnings -$1.794M -$1.577M
YoY Change -51.45% -54.49%
Net Earnings / Revenue
Basic Earnings Per Share -$0.21
Diluted Earnings Per Share -$4.70 -$0.21
COMMON SHARES
Basic Shares Outstanding 12.16M shares 9.614M shares
Diluted Shares Outstanding 387.9K shares 7.603M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $388.2K $118.7K
YoY Change -81.28% -91.15%
Cash & Equivalents $388.2K $118.7K
Short-Term Investments
Other Short-Term Assets $626.8K $415.7K
YoY Change -54.44% 3472.79%
Inventory
Prepaid Expenses
Receivables $1.298M
Other Receivables $0.00
Total Short-Term Assets $2.313M $534.4K
YoY Change -32.95% -89.01%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL ASSETS
Total Short-Term Assets $2.313M $534.4K
Total Long-Term Assets $0.00 $0.00
Total Assets $2.313M $534.4K
YoY Change -46.41% -95.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.638M $1.854M
YoY Change 4.24% 5.56%
Accrued Expenses $570.1K $986.8K
YoY Change -50.17% -50.18%
Deferred Revenue
YoY Change
Short-Term Debt $1.434M $1.670M
YoY Change 73.03%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.454M $4.812M
YoY Change -25.23% -43.34%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.454M $4.812M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $4.454M $4.812M
YoY Change -25.23% -51.1%
SHAREHOLDERS EQUITY
Retained Earnings -$122.2M -$120.4M
YoY Change 6.82% 8.76%
Common Stock $65.31K $47.51K
YoY Change 52.06% 10.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.141M -$4.278M
YoY Change
Total Liabilities & Shareholders Equity $2.313M $534.4K
YoY Change -46.41% -95.94%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$1.794M -$1.577M
YoY Change -51.45% -54.49%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$1.800M -$1.475M
YoY Change -294.09% -49.65%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$1.250M $350.0K
YoY Change -131.4%
Cash From Investing Activities -$1.250M $350.0K
YoY Change -129.55% -822.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.319M 1.150M
YoY Change -854.39%
NET CHANGE
Cash From Operating Activities -1.800M -1.475M
Cash From Investing Activities -1.250M 350.0K
Cash From Financing Activities 3.319M 1.150M
Net Change In Cash 269.5K 25.47K
YoY Change -94.29% -100.86%
FREE CASH FLOW
Cash From Operating Activities -$1.800M -$1.475M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001460702
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity File Number
EntityFileNumber
001-37428
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-3474527
dei Entity Address Address Line1
EntityAddressAddressLine1
5857 Owens Avenue, Suite 300
CY2024Q2 us-gaap Cash
Cash
118685 usd
CY2023Q4 us-gaap Cash
Cash
401803 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
415725 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
534410 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1166767 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
866481 usd
CY2024Q2 us-gaap Assets
Assets
534410 usd
CY2023Q4 us-gaap Assets
Assets
2033248 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1853896 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2222983 usd
CY2024Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
986806 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
560006 usd
CY2024Q2 QLGN Warrant Liabilities Current
WarrantLiabilitiesCurrent
260276 usd
CY2023Q4 QLGN Warrant Liabilities Current
WarrantLiabilitiesCurrent
54600 usd
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
usd
CY2024Q2 QLGN Loss On Issuance Of Convertible Debt
LossOnIssuanceOfConvertibleDebt
usd
CY2023Q2 QLGN Loss On Issuance Of Convertible Debt
LossOnIssuanceOfConvertibleDebt
usd
QLGN Loss On Issuance Of Convertible Debt
LossOnIssuanceOfConvertibleDebt
usd
CY2023Q2 QLGN Gain Loss On Voluntary Conversion Of Convertible Debt Into Common Stock
GainLossOnVoluntaryConversionOfConvertibleDebtIntoCommonStock
usd
CY2023Q2 QLGN Loss On Monthly Redemptions Of Convertible Debt Into Common Stock
LossOnMonthlyRedemptionsOfConvertibleDebtIntoCommonStock
usd
QLGN Loss On Monthly Redemptions Of Convertible Debt Into Common Stock
LossOnMonthlyRedemptionsOfConvertibleDebtIntoCommonStock
usd
CY2024Q2 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
usd
us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
usd
CY2023Q2 us-gaap Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
usd
us-gaap Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
usd
CY2024Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
usd
CY2024Q2 us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
usd
CY2023Q2 us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
usd
us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
usd
QLGN Loss On Monthly Redemptions Of Convertible Debt Into Common Stock
LossOnMonthlyRedemptionsOfConvertibleDebtIntoCommonStock
usd
QLGN Gain Loss On Issuance Of Convertible Debt
GainLossOnIssuanceOfConvertibleDebt
usd
QLGN Fair Value Of Warrant Modification For Professional Services
FairValueOfWarrantModificationForProfessionalServices
usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
usd
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
usd
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
QLGN Monthly Redemption Of Convertible Debt Into Common Stock
MonthlyRedemptionOfConvertibleDebtIntoCommonStock
usd
QLGN Deemed Dividend Arising From Warrant Downround Provision
DeemedDividendArisingFromWarrantDownroundProvision
usd
QLGN Exchange Of Derivative Liability For Warrant And Convertible Debt
ExchangeOfDerivativeLiabilityForWarrantAndConvertibleDebt
usd
QLGN Net Transfers To Equipment Held For Lease From Inventory
NetTransfersToEquipmentHeldForLeaseFromInventory
usd
CY2024Q2 QLGN Prepaid Research And Development Expenses
PrepaidResearchAndDevelopmentExpenses
usd
CY2024Q2 QLGN Funds Held In Escrow Non Current
FundsHeldInEscrowNonCurrent
usd
CY2024Q2 QLGN Longterm Research And Development Deposits
LongtermResearchAndDevelopmentDeposits
usd
CY2024Q2 us-gaap Other Assets
OtherAssets
usd
CY2024Q2 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
usd
us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
usd
CY2023Q2 us-gaap Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
usd
us-gaap Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
usd
CY2024Q2 QLGN Accrued License Fees
AccruedLicenseFees
usd
QLGN Fair Value Of Warrant Liabilities On Date Of Exercise
FairValueOfWarrantLiabilitiesOnDateOfExercise
usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
usd
dei Entity Registrant Name
EntityRegistrantName
Qualigen Therapeutics, Inc.
dei Entity Address City Or Town
EntityAddressCityOrTown
Carlsbad
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92008
dei City Area Code
CityAreaCode
(760)
dei Local Phone Number
LocalPhoneNumber
452-8111
dei Security12b Title
Security12bTitle
Common Stock, par value $.001 per share
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.001
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4812273 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4136805 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
225000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
225000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9613899 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9613899 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
47514 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
43262 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
116086316 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
114655565 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-120411693 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-116802384 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-4277863 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2103557 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
534410 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2033248 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
986484 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2427066 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2047419 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3796068 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
754287 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1174646 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1118672 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2456463 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
1740771 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
3601712 usd
us-gaap Operating Expenses
OperatingExpenses
3166091 usd
us-gaap Operating Expenses
OperatingExpenses
6252531 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1740771 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3601712 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3166091 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-6252531 usd
CY2024Q2 QLGN Gain On Change In Fair Value Of Warrant Liabilities
GainOnChangeInFairValueOfWarrantLiabilities
493206 usd
CY2023Q2 QLGN Gain On Change In Fair Value Of Warrant Liabilities
GainOnChangeInFairValueOfWarrantLiabilities
440294 usd
QLGN Gain On Change In Fair Value Of Warrant Liabilities
GainOnChangeInFairValueOfWarrantLiabilities
359906 usd
QLGN Gain On Change In Fair Value Of Warrant Liabilities
GainOnChangeInFairValueOfWarrantLiabilities
1478967 usd
CY2024Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
10116 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
174613 usd
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
263560 usd
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
377416 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
400117 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
921652 usd
QLGN Loss On Issuance Of Convertible Debt
LossOnIssuanceOfConvertibleDebt
358279 usd
CY2024Q2 QLGN Gain Loss On Voluntary Conversion Of Convertible Debt Into Common Stock
GainLossOnVoluntaryConversionOfConvertibleDebtIntoCommonStock
83800 usd
QLGN Gain Loss On Voluntary Conversion Of Convertible Debt Into Common Stock
GainLossOnVoluntaryConversionOfConvertibleDebtIntoCommonStock
83800 usd
QLGN Gain Loss On Voluntary Conversion Of Convertible Debt Into Common Stock
GainLossOnVoluntaryConversionOfConvertibleDebtIntoCommonStock
-1077287 usd
CY2024Q2 QLGN Loss On Monthly Redemptions Of Convertible Debt Into Common Stock
LossOnMonthlyRedemptionsOfConvertibleDebtIntoCommonStock
61655 usd
QLGN Loss On Monthly Redemptions Of Convertible Debt Into Common Stock
LossOnMonthlyRedemptionsOfConvertibleDebtIntoCommonStock
208852 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1094 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5509 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2713 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5509 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
263001 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
68387 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-346216 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-514463 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1477770 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3533325 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3512307 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6766994 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1212 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4036 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2998 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5429 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1476558 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-3537361 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-3509309 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-6772423 usd
CY2023Q2 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
29672 usd
us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
-842515 usd
CY2024Q2 us-gaap Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
100000 usd
us-gaap Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
100000 usd
CY2024Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-100000 usd
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
29672 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-100000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-842515 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-1576558 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-3507689 usd
us-gaap Profit Loss
ProfitLoss
-3609309 usd
us-gaap Profit Loss
ProfitLoss
-7614938 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-43484 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-304512 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1576558 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3464205 usd
us-gaap Net Income Loss
NetIncomeLoss
-3609309 usd
us-gaap Net Income Loss
NetIncomeLoss
-7310426 usd
us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
60017 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1576558 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3464205 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3669326 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7310426 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.20
CY2024Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.20
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.70
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.70
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.53
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.53
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-1.35
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-1.35
CY2024Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.01
CY2024Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.01
CY2023Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0.01
CY2023Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0.01
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.01
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.01
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.11
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.11
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.69
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.69
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.46
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.46
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7603252 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7603252 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5052463 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5052463 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6773533 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6773533 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5006050 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5006050 shares
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-1576558 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-3507689 usd
us-gaap Profit Loss
ProfitLoss
-3609309 usd
us-gaap Profit Loss
ProfitLoss
-7614938 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-56747 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
119473 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1576558 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-3564436 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-3609309 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-7495465 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-43484 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-304512 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1576558 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3520952 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3609309 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7190953 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2103557 usd
CY2024Q1 QLGN Stock Issued During Period Value Monthly Redemptions Of Convertible Debt Into Common Stock
StockIssuedDuringPeriodValueMonthlyRedemptionsOfConvertibleDebtIntoCommonStock
546232 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
9737 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
58651 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-2032751 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-3521688 usd
CY2024Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
280201 usd
CY2024Q2 QLGN Stock Issued During Period Value Monthly Redemptions Of Convertible Debt Into Common Stock
StockIssuedDuringPeriodValueMonthlyRedemptionsOfConvertibleDebtIntoCommonStock
357096 usd
CY2024Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
150000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
33086 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-1576558 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-4277863 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8766590 usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1112582 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
252226 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest
176220 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-4107249 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6200369 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6200369 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
672111 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest
-56747 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-3507689 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3308044 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3308044 usd
us-gaap Profit Loss
ProfitLoss
-3609309 usd
us-gaap Profit Loss
ProfitLoss
-7614938 usd
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-100000 usd
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-842515 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-3509309 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-6772423 usd
us-gaap Share Based Compensation
ShareBasedCompensation
91737 usd
us-gaap Share Based Compensation
ShareBasedCompensation
886442 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-359906 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1478967 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
174613 usd
QLGN Gain Loss On Voluntary Conversion Of Convertible Debt
GainLossOnVoluntaryConversionOfConvertibleDebt
-83800 usd
QLGN Gain Loss On Voluntary Conversion Of Convertible Debt
GainLossOnVoluntaryConversionOfConvertibleDebt
1077287 usd
QLGN Loss On Monthly Redemptions Of Convertible Debt Into Common Stock
LossOnMonthlyRedemptionsOfConvertibleDebtIntoCommonStock
208852 usd
QLGN Accretion Of Discount On Convertible Debt
AccretionOfDiscountOnConvertibleDebt
-322717 usd
QLGN Accretion Of Discount On Convertible Debt
AccretionOfDiscountOnConvertibleDebt
-787517 usd
QLGN Gain Loss On Issuance Of Convertible Debt
GainLossOnIssuanceOfConvertibleDebt
-358279 usd
QLGN Fair Value Of Warrant Modification For Professional Services
FairValueOfWarrantModificationForProfessionalServices
9737 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-765720 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-185308 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-369088 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
630288 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
481556 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
321973 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-2258118 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4362575 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-1199841 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2258118 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5562416 usd
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
350000 usd
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-246418 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
350000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-246418 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
1475000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
150000 usd
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1625000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1625000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-283118 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-5808834 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
115803 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
401803 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3165985 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
3874139 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
756456 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118685 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
590636 usd
us-gaap Interest Paid Net
InterestPaidNet
1020 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2860 usd
QLGN Monthly Redemption Of Convertible Debt Into Common Stock
MonthlyRedemptionOfConvertibleDebtIntoCommonStock
903329 usd
QLGN Voluntary Conversion Of Convertible Debt Into Common Stock
VoluntaryConversionOfConvertibleDebtIntoCommonStock
280200 usd
QLGN Voluntary Conversion Of Convertible Debt Into Common Stock
VoluntaryConversionOfConvertibleDebtIntoCommonStock
1112582 usd
QLGN Deemed Dividend Arising From Warrant Downround Provision
DeemedDividendArisingFromWarrantDownroundProvision
-60017 usd
QLGN Exchange Of Derivative Liability For Warrant And Convertible Debt
ExchangeOfDerivativeLiabilityForWarrantAndConvertibleDebt
-675625 usd
QLGN Net Transfers To Equipment Held For Lease From Inventory
NetTransfersToEquipmentHeldForLeaseFromInventory
-35971 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_846_eus-gaap--UseOfEstimates_zZqG7Sh1cLd2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zygVoM6UUF8g">Accounting Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management uses estimates and assumptions in preparing its condensed consolidated financial statements in accordance with U.S. GAAP. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. The most significant estimates relate to the estimated fair value of in-process research and development, goodwill, warrant liabilities, and stock-based compensation. Actual results could materially vary from the estimates that were used.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span><b><i> </i></b></p>
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2024Q2 us-gaap Cash
Cash
119000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-120400000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2300000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10300000 usd
CY2022Q4 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
3000000.0 usd
CY2024Q2 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1500000 usd
CY2024Q2 us-gaap Prepaid Insurance
PrepaidInsurance
382229 usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
566011 usd
CY2024Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
33496 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
25053 usd
CY2023Q4 QLGN Prepaid Research And Development Expenses
PrepaidResearchAndDevelopmentExpenses
173900 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
415725 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
764964 usd
CY2023Q4 QLGN Funds Held In Escrow Non Current
FundsHeldInEscrowNonCurrent
450000 usd
CY2023Q4 QLGN Longterm Research And Development Deposits
LongtermResearchAndDevelopmentDeposits
416481 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
866481 usd
CY2023Q2 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
29672 usd
us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
-842515 usd
CY2024Q2 us-gaap Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
100000 usd
us-gaap Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
100000 usd
CY2024Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-100000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-100000 usd
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
29672 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-842515 usd
CY2024Q2 us-gaap Escrow Deposits Related To Property Sales
EscrowDepositsRelatedToPropertySales
350000 usd
CY2024Q2 us-gaap Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
100000 usd
us-gaap Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
100000 usd
CY2024Q2 QLGN Accrued Compensation
AccruedCompensation
251999 usd
CY2023Q4 QLGN Accrued Compensation
AccruedCompensation
129499 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
51909 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
10004 usd
CY2023Q4 QLGN Accrued License Fees
AccruedLicenseFees
32975 usd
CY2024Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
300481 usd
CY2023Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1215 usd
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
144528 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
121775 usd
CY2024Q2 QLGN Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
17500 usd
CY2023Q4 QLGN Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
104402 usd
CY2024Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
162665 usd
CY2023Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
151286 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
57725 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8850 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
986806 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
560006 usd
CY2024Q2 QLGN Fair Value Of Warrant Liabilities On Date Of Granted
FairValueOfWarrantLiabilitiesOnDateOfGranted
565582 usd
CY2024Q2 QLGN Warrant Liabilities Current
WarrantLiabilitiesCurrent
260276 usd
CY2024Q2 QLGN Gain On Change In Fair Value Of Warrants
GainOnChangeInFairValueOfWarrants
305306 usd
CY2023Q4 QLGN Fair Value Adjustment Of Warrant
FairValueAdjustmentOfWarrant
54600 usd
QLGN Fair Value Of Warrant Liabilities On Date Of Granted
FairValueOfWarrantLiabilitiesOnDateOfGranted
565582 usd
QLGN Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
-359906 usd
CY2024Q2 QLGN Fair Value Adjustment Of Warrant
FairValueAdjustmentOfWarrant
260276 usd
QLGN Derivative Liabilities Issuanceof Convertible Debt
DerivativeLiabilitiesIssuanceofConvertibleDebt
215897 usd
QLGN Gain On Change In Fair Value Of Derivative Liabilities
GainOnChangeInFairValueOfDerivativeLiabilities
-174613 usd
CY2024Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
41284 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9716650 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4565097 shares
CY2024Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
9716650 shares
CY2024Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
9716650 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
120000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y11M4D
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
33086 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
643900 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
91737 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
886442 usd
CY2023Q4 QLGN Bid Price
BidPrice
1.00
CY2023Q4 QLGN Minimum Stockholders Equity Requirement Nasdaq Amount
MinimumStockholdersEquityRequirementNasdaqAmount
2500000 usd

Files In Submission

Name View Source Status
0001493152-24-032161-index-headers.html Edgar Link pending
0001493152-24-032161-index.html Edgar Link pending
0001493152-24-032161.txt Edgar Link pending
0001493152-24-032161-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
qlgn-20240630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
qlgn-20240630_cal.xml Edgar Link unprocessable
qlgn-20240630_def.xml Edgar Link unprocessable
qlgn-20240630_lab.xml Edgar Link unprocessable
qlgn-20240630_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable